Live Breaking News & Updates on Society For Urologic Oncology

Stay updated with breaking news from Society for urologic oncology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Francis Collins Discloses His 'Aggressive' Prostate Cancer Diagnosis

Former NIH director said he went public to 'share lifesaving information' ....

United States , Mike Bassett , Francis Collin , Ellen Sigal , Xavier Becerra , Franciss Collins , Friends Of Cancer Research , American Urological Association , Us Preventive Services Task Force , Washington Post , Society For Urologic Oncology , Services Task Force , Urologic Oncology , Cancer Research ,

Twenty-three Georgia Urology physicians receive Top Doctors honors in Atlanta magazine

Twenty-three Georgia Urology physicians receive Top Doctors honors in Atlanta magazine
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , University Of Chicago , Fox Chase Cancer Center , Emory University , San Diego , Washington University , Baylor College Of Medicine , Vanderbilt University , University Of Texas At San Antonio , Jewish Hospital , Dekalb Medical Center , Temple University , Morehouse College , University Of Pennsylvania , Rice University , University Of Miami , Sandy Springs , New York , Columbia University , Williams College , University Of Illinois , University Of Texas , Boston University , Beth Israel Medical Center , New York University , Clark Atlanta University ,

2 Clayton County physicians ranked among Top Doctors in Atlanta Magazine

ATLANTA — Twenty-three physicians from Georgia Urology — the largest urology practice in Georgia — rank among Atlanta’s Top Doctors in Atlanta magazine’s July issue including Riverdale physicians Dr. Daniel ....

New York , United States , Beth Israel Medical Center , New York University , Michael Garcia Roig , Wolfgang Cerwinka , Mark Haber , Emily Blum , Walter Falconer , Hal Scherz , Ronald Anglade , Robert Chen , Dan Fellner , Froylan Gonzalez , Joel Rosenfeld , Warren Todd Oberle , Roosevelt Allen , Andrew Kirsch , John Abbott , Barrym Zisholtz , Lewis Kriteman , Barry Zisholtz , Edwin Smith , Shaya Taghechian , Carl Capelouto , Research Service ,

Twenty-one Georgia Urology physicians receive Top Doctors honors in Atlanta

Twenty-one Georgia Urology physicians receive Top Doctors honors in Atlanta
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

United States , Fox Chase Cancer Center , Emory University , Williams College , San Diego , Georgia Camp Creek , New York , Baylor College Of Medicine , University Of Texas At San Antonio , Dekalb Medical Center , Morehouse College , University Of Pennsylvania , New York Hospital , Georgetown University , District Of Columbia , Sandy Springs , Ohio State University , Columbia University , University Of Texas , Beth Israel Medical Center , University Of Texas Southwestern Medical Center , New York University , Clark Atlanta University , Metropolitan Hospital , University Of Tennessee , Emory University School Of Medicine ,

SUO 2020: Debate: Relugolix for Advanced Prostate Cancer is the New Standard (The HERO Study)

SUO 2020: Debate: Relugolix for Advanced Prostate Cancer is the New Standard (The HERO Study)
(UroToday.com) During the second prostate cancer session at the 2020 Annual Meeting of the Society of Urologic Oncology (SUO), Drs. Neal Shore and Ashley Evan Ross debated the use of relugolix as a new standard of care for androgen deprivation therapy (ADT) for the treatment of prostate cancer.
This debate follows the publication of the HERO trial,
1
A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer (HERO), which was published in the New England Journal of Medicine in June 2020 and of which Dr. Shore is the lead author. This was a randomized controlled comparing relugolix, an oral gonadotropin-releasing hormone antagonist, to leuprolide. 120mg relugolix was given by mouth daily and leuprolide was given every 3 months as depot injections. The primary end point was “sustained castration”, meaning a testosterone level ....

United States , Fox Chase Cancer Center , Marshall Strother , Ashley Ross , Ashley Evan Ross , Society Of Urologic Oncology Annual Meeting , Carolina Urologic Research Center , Division Of Urologic Oncology , Meeting Of The Society Urologic Oncology , United States Federal Drug Administration , Northwestern Medical Group , Health Drug , Feinberg School Of Medicine , Society For Urologic Oncology , Urologic Oncology , Neal Shore , Men With Advanced Prostate Cancer , New England Journal , Medical Director , Carolina Urologic Research , Associate Professor , Feinberg School , Northwestern Medical , Urologic Oncology Fellow , Urologic Oncology Annual Meeting , Treatment Patterns ,